IP Library Granted Patent US 9,585,905
Granted Patent B2
US 9,585,905 · App. 15/194,411 · Granted Mar 7, 2017

Sweet taste receptor antagonist compositions

Inventors: Robert L. Goldstein (New York, NY); Grant Dubois (Roswell, GA); Arianne Perry (New York, NY)
Assignee: Four LLC
A61K31/704A23G3/362A23G3/38A23G3/48A23L3/205A23L27/86A23L33/105A23L33/165A23L33/20A61K8/27A61K8/368A61K8/58A61K8/602A61K9/0053A61K9/0056A61K9/20A61K31/315A61K33/24A61K38/168A61K45/06A61Q11/00A23V2002/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,585,905
App. No.
15/194,411
Granted
Mar 7, 2017
Kind
B2
Abstract

The present disclosure relates to compositions comprising gymnemic acid, together with a form of zinc to block the unpleasant bitter taste of gymnemic acid as well as to extend the sweet taste blocking properties of gymnemic acid, resulting in palatable compositions for delivery to the oral cavity to block sweet taste receptors located therein. The present disclosure also relates to methods of reducing sugar consumption and reducing calorie intake via administration of such compositions to a subject.

Claims (16)

1. A composition comprising at least one form of gymnemic acid and at least one form of zinc, wherein a weight ratio of the at least one form of gymnemic acid to zinc ion in the at least one form of zinc is less than 5.1, wherein the composition is a lingual delivery form which is an orally disintegrating tablet having a disintegration time in the range of from about 30 seconds to about 5 minutes.

2. A composition comprising at least one form of gymnemic acid and at least one form of zinc, wherein a weight ratio of the at least one form of gymnemic acid to zinc ion in the at least one form of zinc is less than 5.1, wherein the at least one form of zinc is selected from zinc acetate, zinc carbonate, zinc chloride, zinc citrate, zinc gluconate, zinc sulfate, zinc hydrosulfite, zinc bisulfate, zinc oxide, zinc halide, zinc hydride, zinc carbide, and combinations thereof.

3. The composition of claim 2 , wherein the at least one form of zinc is zinc gluconate.

4. A composition comprising at least one form of gymnemic acid and at least one form of zinc, wherein a weight ratio of the at least one form of gymnemic acid to zinc ion in the at least one form of zinc is less than 5.1, wherein the at least one form of gymnemic acid is present in the range of from about 1 to about 10 mg.

5. The composition of claim 4 , wherein the at least one form of gymnemic acid is present in the range of from about 1 to about 5 mg.

6. A composition comprising at least one form of gymnemic acid and at least one form of zinc, wherein a weight ratio of the at least one form of gymnemic acid to zinc ion in the at least one form of zinc is less than 5.1, further comprising mint.

7. A lingual delivery form comprising at least one form of gymnemic acid and at least one form of zinc, wherein the at least one form of gymnemic acid is present in the range of from about 0.1 mg to about 10 mg and the at least one form of zinc is present in the range of about 1 mg to about 10 mg.

8. The lingual delivery form of claim 7 , wherein the at least one form of zinc is zinc gluconate.

9. The lingual delivery form of claim 7 , wherein the delivery form is an orally disintegrating tablet.

10. The lingual delivery form of claim 7 , wherein the at least one form of gymnemic acid is present in the range of from about 1 mg to about 5 mg.

11. The lingual delivery form of claim 8 , wherein the zinc gluconate is present in the range of about 7 mg to about 9 mg.

12. The lingual delivery form of claim 11 , wherein the at least one form of gymnemic acid is present in the range of from about 2 mg to about 4 mg.

13. The lingual delivery form of claim 12 , further comprising mint.

14. A method of reducing calorie intake, comprising administering a composition comprising at least one form of gymnemic acid and at least one form of zinc, wherein a weight ratio of the at least one form of gymnemic acid to zinc ion in the at least one form of zinc is less than 5.1, wherein the composition is an orally disintegrating tablet.

15. A method of reducing calorie intake, comprising administering a composition comprising at least one form of gymnemic acid and at least one form of zinc, wherein a weight ratio of the at least one form of gymnemic acid to zinc ion in the at least one form of zinc is less than 5.1, wherein the composition further comprises mint.

16. A method of reducing dental caries, comprising administering a composition comprising at least one form of gymnemic acid and at least one form of zinc, wherein a weight ratio of the at least one form of gymnemic acid to zinc ion in the at least one form of zinc is less than 2.8, and wherein the at least one form of zinc is zinc gluconate.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 28, 2018
From: CRAVE CRUSH, LLC
To: SWEET DEFEAT, LLC
Reel/Frame 047612/0014 →
CHANGE OF NAME Recorded Oct 25, 2018
From: FOUR LLC
To: CRAVE CRUSH LLC
Reel/Frame 047321/0992 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 1, 2016
From: DUBOIS, GRANT; GOLDSTEIN, ROBERT L.; PERRY, ARIANNE
To: FOUR LLC
Reel/Frame 040484/0601 →
Continuity (4)
Continuation 14738326 · Jun 12, 2015
Provisional Application 62025725 · Jul 17, 2014
Provisional Application 62011096 · Jun 12, 2014
Related Publication 20160303149A1 · Oct 20, 2016